Mostrar el registro sencillo del ítem
dc.contributor.author | Marin-Paya, Juan Carlos | es_ES |
dc.contributor.author | Clara-Trujillo, Sandra | es_ES |
dc.contributor.author | Cordón, Lourdes | es_ES |
dc.contributor.author | Gallego-Ferrer, Gloria | es_ES |
dc.contributor.author | Sempere, Amparo | es_ES |
dc.contributor.author | Gómez Ribelles, José Luís | es_ES |
dc.date.accessioned | 2023-04-21T18:01:43Z | |
dc.date.available | 2023-04-21T18:01:43Z | |
dc.date.issued | 2022-11 | es_ES |
dc.identifier.uri | http://hdl.handle.net/10251/192919 | |
dc.description.abstract | [EN] Multiple myeloma is a hematologic neoplasm caused by an uncontrolled clonal proliferation of neoplastic plasma cells (nPCs) in the bone marrow. The development and survival of this disease is tightly related to the bone marrow environment. Proliferation and viability of nPCs depend on their interaction with the stromal cells and the extracellular matrix components, which also influences the appearance of drug resistance. Recapitulating these interactions in an in vitro culture requires 3D environments that incorporate the biomolecules of interest. In this work, we studied the proliferation and viability of three multiple myeloma cell lines in a microgel consisting of biostable microspheres with fibronectin (FN) on their surfaces. We also showed that the interaction of the RPMI8226 cell line with FN induced cell arrest in the G0/G1 cell cycle phase. RPMI8226 cells developed a significant resistance to dexamethasone, which was reduced when they were treated with dexamethasone and bortezomib in combination. | es_ES |
dc.description.sponsorship | This research was funded by the Generalitat Valenciana, grant number PROMETEO/2016/063; JLGR acknowledges that support by was funded by the Spanish State Research Agency (AEI) through the PID2019-106099RB-C41/AEI/10.13039/501100011033 project. | es_ES |
dc.language | Inglés | es_ES |
dc.publisher | MDPI AG | es_ES |
dc.relation.ispartof | Biomedicines | es_ES |
dc.rights | Reconocimiento (by) | es_ES |
dc.subject | Multiple myeloma | es_ES |
dc.subject | Microgel | es_ES |
dc.subject | Fibronectin | es_ES |
dc.subject | Dexamethasone | es_ES |
dc.subject | Bortezomib | es_ES |
dc.subject.classification | MAQUINAS Y MOTORES TERMICOS | es_ES |
dc.title | Protein-Functionalized Microgel for Multiple Myeloma Cells' 3D Culture | es_ES |
dc.type | Artículo | es_ES |
dc.identifier.doi | 10.3390/biomedicines10112797 | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2019-106099RB-C41/ES/MICROGELES BIOMIMETICOS PARA EL ESTUDIO DE LA GENERACION DE RESISTENCIAS A FARMACOS EN EL MIELOMA MULTIPLE/ | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/GVA//PROMETEO%2F2016%2F063//MEDULA OSEA ARTIFICIAL PARA PERSONALIZAR EL TRATAMIENTO DE PACIENTES DE CANCERES DE SANGRE/ | es_ES |
dc.rights.accessRights | Abierto | es_ES |
dc.contributor.affiliation | Universitat Politècnica de València. Escuela Técnica Superior de Ingenieros Industriales - Escola Tècnica Superior d'Enginyers Industrials | es_ES |
dc.description.bibliographicCitation | Marin-Paya, JC.; Clara-Trujillo, S.; Cordón, L.; Gallego-Ferrer, G.; Sempere, A.; Gómez Ribelles, JL. (2022). Protein-Functionalized Microgel for Multiple Myeloma Cells' 3D Culture. Biomedicines. 10(11):1-12. https://doi.org/10.3390/biomedicines10112797 | es_ES |
dc.description.accrualMethod | S | es_ES |
dc.relation.publisherversion | https://doi.org/10.3390/biomedicines10112797 | es_ES |
dc.description.upvformatpinicio | 1 | es_ES |
dc.description.upvformatpfin | 12 | es_ES |
dc.type.version | info:eu-repo/semantics/publishedVersion | es_ES |
dc.description.volume | 10 | es_ES |
dc.description.issue | 11 | es_ES |
dc.identifier.eissn | 2227-9059 | es_ES |
dc.identifier.pmid | 36359316 | es_ES |
dc.identifier.pmcid | PMC9687145 | es_ES |
dc.relation.pasarela | S\483858 | es_ES |
dc.contributor.funder | Generalitat Valenciana | es_ES |
dc.contributor.funder | Instituto de Salud Carlos III | es_ES |
dc.contributor.funder | AGENCIA ESTATAL DE INVESTIGACION | es_ES |
dc.contributor.funder | European Regional Development Fund | es_ES |
dc.contributor.funder | Ministerio de Ciencia e Innovación | es_ES |
dc.contributor.funder | Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina | es_ES |
dc.subject.ods | 03.- Garantizar una vida saludable y promover el bienestar para todos y todas en todas las edades | es_ES |